Cardiol Therapeutics Inc.
CRDL.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.28M | -7.78M | -5.17M | -7.23M | -6.04M |
| Total Depreciation and Amortization | 8.10K | 19.20K | 18.60K | 18.60K | 18.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 643.70K | 2.27M | 1.86M | 2.64M | 2.25M |
| Change in Net Operating Assets | 547.00K | 85.60K | -452.40K | -451.70K | 485.20K |
| Cash from Operations | -3.08M | -5.41M | -3.75M | -5.03M | -3.29M |
| Capital Expenditure | -2.10K | -34.20K | -2.20K | -2.20K | -4.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.10K | -34.20K | -2.20K | -2.20K | -4.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.80K | -13.80K | -13.80K | -13.80K | -13.80K |
| Issuance of Common Stock | 2.49M | 14.85M | 16.04M | 0.00 | 34.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.24M | -477.00K | -- | -- |
| Cash from Financing | 1.74M | 9.78M | 11.15M | -10.10K | 14.80K |
| Foreign Exchange rate Adjustments | 220.50K | 159.60K | -376.20K | 268.10K | -405.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.12M | 4.50M | 7.03M | -4.77M | -3.68M |